References
- Benita, S., Levy, M.Y. (1993). Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization. J Pharm Sci. 82, 1069–79.
- Brange, J., Langkjaer, L. (1997). Insulin formulation and delivery. Pharm Biotechnol. 10, 343–409.
- Carlson, M.G., Campbell, P.J. (1993). Intensive insulin therapy and weight gain in IDDM. Diabetes. 42, 1700–7.
- Chen, H., Langer, R. (1998). Oral particulate delivery: status and future trends. Adv Drug Deliv Rev. 34, 339–50.
- Chernysheva, Y., Babak, V., Kildeeva, N., Boury, F., Benoit, J.P., Ubrich, N., Maincent, P. (2003). Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporation. Mendeleev Commun. 13, 65–8.
- Damgé, C., Maincent, P., Ubrich, N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Contr Rel. 117, 163–70.
- Damgé, C., Michel, C., Aprahamian, M., Couvreur, P. (1988). New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 37, 246–51.
- Damgé, C., Reis, C.P., Maincent, P. (2008). Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv. 5, 45–68.
- Damgé, C., Vranckx, H., Balschmidt, P., Couvreur, P. (1997). Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J Pharm Sci. 86, 1403–9.
- Hoffart, V., Lamprecht, A., Maincent, P., Lecompte, T., Vigneron, C., Ubrich, N. (2006). Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J Contr Rel. 113, 38–42.
- Hoffart, V., Ubrich, N., Lamprecht, A., Bachelier, K., Vigneron, C., Lecompte, T., Hoffman, M., Maincent, P. (2003). Microencapsulation of low molecular weight heparin into polymeric particles designed with biodegradable and nonbiodegradable polycationic polymers. Drug Deliv. 10, 1–7.
- Jameela, S.R., Suma, N., Jayakrishnan, A. (1997). Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J Biomater Sci Polym Ed. 8, 457–66.
- Jiao, Y., Ubrich, N., Hoffart, V., Marchand-Arvier, M., Vigneron, C., Hoffman, M., Maincent, P. (2002a). Preparation and characterization of heparin-loaded polymeric microparticles. Drug Dev Ind Pharm. 28, 1033–41.
- Jiao, Y., Ubrich, N., Marchand-Arvier, M., Vigneron, C., Hoffman, M., Lecompte, T., Maincent, P. (2002b). In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation. 105, 230–5.
- Kennedy, F.P. (1991). Recent developments in insulin delivery techniques. Current status and future potential. Drugs. 42, 213–27.
- Lamprecht, A., Koenig, P., Ubrich, N., Maincent, P., Neumann, D. (2006). Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells. Nanotechnology. 17, 3673–80.
- Lewis, G.F., Zinman, B., Groenewoud, Y., Vranic, M., Giacca, A. (1996). Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 45, 454–62.
- Monaco, L., Geffken, G., Silverstein, J.H. (1996). Accuracy of injection site identification among children with insulin dependent diabetes mellitus: a comparison of traditional and new visual aids. Clin Pediatr (Phila). 35, 191–7.
- Owens, D.R., Zinman, B., Bolli, G. (2003). Alternative routes of insulin delivery. Diabet Med. 20, 886–98.
- Pauletti, G.M., Gangwar, S., Knipp, G.T., Nerurkar, M.M., Okumu, F.W., Tamura, K., Siahaan, T.J., Borchardt, R.T. (1996). Structural requirements for intestinal absorption of peptide drugs. J Contr Rel. 41, 3–17.
- Peppas, N.A., Kavimandan, N.J. (2006). Nanoscale analysis of protein and peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. Eur J Pharm Sci. 29, 183–97.